Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors

Giulio Poli, Margherita Lapillo, Carlotta Granchi, Jessica Caciolla, Nayla Mouawad, Isabella Caligiuri, Flavio Rizzolio, Thierry Langer, Filippo Minutolo, Tiziano TuccinardiJournal of Enzyme Inhibition and Medicinal Chemistry 2025 · OpenReview

Abstract

Fyn tyrosine kinase inhibitors are considered potential therapeutic agents for a variety of human cancers. Furthermore, the involvement of Fyn kinase in signalling pathways that lead to severe pathologies, such as Alzheimer’s and Parkinson’s diseases, has also been demonstrated. In this study, starting from 3-(benzo[d][1,3]dioxol-5-ylamino)-6-methyl-1,2,4-triazin-5(2H)-one (VS6), a hit compound that showed a micromolar inhibition of Fyn (IC50 = 4.8 μM), we computationally investigated the binding interactions of the 3-amino-1,2,4-triazin-5(2H)-one scaffold and started a preliminary hit to lead optimisation. This analysis led us to confirm the hypothesised binding mode of VS6 and to identify a new derivative that is about 6-fold more active than VS6 (compound 3, IC50 = 0.76 μM).
BibTeX
@article{poli2025binding,
  author = {Giulio Poli and Margherita Lapillo and Carlotta Granchi and Jessica Caciolla and Nayla Mouawad and Isabella Caligiuri and Flavio Rizzolio and Thierry Langer and Filippo Minutolo and Tiziano Tuccinardi},
  title = {{Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors}},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2025},
  url = {https://openreview.net/forum?id=RqZcSKlC9h},
}

Loading related content...

Figure